Research News - November 10, 2017

  F Youtube T IN
November 10, 2017

1. Call for Abstracts: Scientific Advisory Committee (SAC) 2018 Poster Session
2. REDCap Report FY17
3. Seminar Series: MGH Global Health Research and Implementation Unit



1. MGH/Harvard Cutaneous Biology Research Center Seminar Series
2. MGH Immunology Seminar Series
3. REDCap Course Offerings
4. Division of Clinical Research Spotlight Series: Pitching/Consenting Research Opportunities in Acutely Ill Subject Populations
5. R Intro Training
6. LabArchives User Group Session
7. Cold Spring Harbor Workshop on Leadership in Bioscience


1. Deliberative Interim Support Funding
2. MGH-MIT Strategic Partnership Grand Challenge 1: Diagnostics, Year 4
3. W.M. Keck Foundation Medical Research Program
4. President’s Innovation Challenge
5. Limited Submission Funding Opportunities
6. Private Funding Opportunities
7. NIH Update for Week Ending November 10, 2017

In Case You Missed It
Reminders of recently posted funding opportunities, deadlines and events
1. Call for Abstracts: Scientific Advisory Committee (SAC) 2018 Poster Session

Now is the chance to exhibit your research!
ECOR is now accepting abstracts for the 2018 SAC Poster Session
Deadline for submission:  Tuesday, January 9, 2018

The Scientific Advisory Committee (SAC) Poster Session gives researchers the opportunity to create a compelling visual display of their work and present it to some of the best scientific minds in the nation. The poster session is an essential part of the two-day meeting, which highlights excellence in research at MGH. Twelve Posters of Distinction will be chosen to receive a $1,000 travel award. A review panel will select a group of finalists from the submitted abstracts. Those finalists will be required to present their poster in order to be considered for the travel award. Awards will be restricted to junior faculty and trainees (i.e. Assistant Professors, Instructors, Fellows, and Graduate Students).

Poster abstract submissions will be accepted on a first come, first served basis.  Authors must be MGH employees.  Abstracts on any type of research are eligible for submission and authors may only submit ONE abstract.  

Simches Building, 185 Cambridge St., 2nd Floor (SERI)
Wednesday, March 28, 2018
Session 1:  10:00am – 11:30am
Session 2:  12:00pm – 1:30pm

*Submitted posters will be placed in a session based on the selected category

Twelve $1,000 Poster of Distinction Awards will be awarded and are intended to help offset the costs of travel to a scientific meeting.

Please click here for more information and to submit a poster abstract!

If you have problems or questions please email

Again, space is limited! Submit your abstract early!

2. REDCap Report FY17

The REDCap program has over 11,000 projects and is steadily growing. See how far REDCap has come at Partners HealthCare since 2009 and where we stand today. REDCap (Research Electronic Data Capture) is a free, secure, HIPAA compliant web-based application hosted by Enterprise Research IS (ERIS). This software application is for electronic collection and management of research and clinical study data.

3. Seminar Series: MGH Global Health Research and Implementation Unit

The Global Heath Research Unit (GHRU) would like to circulate a survey to help inform the development of a seminar series regarding global health research at MGH.  The target audience for this survey is anyone who is currently, or wishes to become involved in global health research at MGH.

Here is the link to the survey:

Back to top
1. MGH/Harvard Cutaneous Biology Research Center Seminar Series

Monday, November 13, 2017, 4pm to 5pm, CNY 149, Isselbacher Auditorium, 7th Floor

“Transit-Amplifying Cells: the real governor of tissue regeneration”
Ya-Chieh Hsu, PhD
Assistant Professor, Harvard University
Department of Stem Cell and Regenerative Biology, Harvard University

2. MGH Immunology Seminar Series

Thursday, November 16, 2017 @ 12:00 PM, CNY 149, 7th Floor, Isselbacher Auditorium

Title: “IVIG-Inspired Drugs for Improved Therapy in Autoimmune Diseases”
Speaker: Carlos Bosques, PhD, Momenta Pharmaceuticals

Will be broadcasted MGH Bulfinch 165 & Ragon Institute (400 Tech sq, Cambridge)

Contact Person – Fiona Chen (617/726-1527)

3. REDCap Course Offerings

REDCap: API and DET User Group Meeting
Wednesday, November 29 | 9:30am-11:00am | Simches 3.120
Learn more about this course.

Thursday, November 30 | 9:30am – 11:00am | Simches 3.120
Learn more about this course.

REDCap v7.4: New Feature Release and User Group Meeting
Wednesday, December 6 | 9:30am – 11:00am | Simches 3.120
Learn more about this course.

REDCap: eConsent
Thursday, December 7 | 9:30am – 11:00am | Simches 3.120
Learn more about this course.

Registration is required for all courses. Contact Cassidy Peters with questions.

4. Division of Clinical Research Spotlight Series: Pitching/Consenting Research Opportunities in Acutely Ill Subject Populations

Wednesday, December 13th, 1:00pm – 2:00pm, Simches Room 3.120

Speaker: Zora DiPucchio, Sr. Clinical Research Coordinator, MGH Neurology

This course focuses on the “soft skills” needed when approaching potential research subjects, who are inpatients. Ms. DiPucchio will discuss the best practices for involving inpatients in research including how to approach the family of a potential subject, who is “comfort measures only (CMO),” and what information to look for in the progress notes before entering a patient’s room.

This program meets the requirements of the Board of Registration in Nursing, at 244 CMR 5.00, for 1 contact hour of nursing continuing education.

Registration is required. Contact Cassidy Peters with further questions about this session.

5. R Intro Training

This training session will be offered on two different dates and locations. Please sign up for the one that works best for you.

Thursday, November 30 from 9:00a.m.-4p.m., One Brigham Circle, Room 4-002B, BWH - REGISTER
Monday, January 29 from 9:00a.m.-4p.m., Simches 3.120, MGH - REGISTER

R is a free, open-source programming language and software environment for statistical computing and graphics. This training course targets research scientists who have no or little knowledge of R. The hands-on training will provide many examples and exercises on ways to use R including computation, data manipulation, plots and installs. 

6. LabArchives User Group Session

Tuesday, December 12, 2:00pm-3:30pm, Simches 3.120

Enterprise Research Infrastructure & Services, ERIS, has an enterprise license for LabArchives for all researchers to use at no cost. LabArchives is a web-based application designed for scientists to organize and share laboratory data with their study team, department, across Partners institutions and with external collaborators. Access rights are controlled by the notebook owner and can be modified to suit the individual needs of each researcher, educator, or contributor.

This session is for LabArchives users, new and current, to meet and discuss how sites/labs are using the application, lessons learned, and share knowledge.

More information and how to access LabArchives is available on the Research IS Computing website.

Registration is required. Contact Cassidy Peters with questions.
7. Cold Spring Harbor Workshop on Leadership in Bioscience

March 23 - 26, 2018, Cold Spring Harbor, NY

Application Deadline: January 31, 2018

Carl M. Cohen, Workshop Director 
Suzanne L. Cohen, Workshop Co-Facilitator
Marquita M. Qualls, Guest Instructor
See the roll of honor - who's taken the course in the past 

This is a highly interactive 3.5 day workshop in which you will develop the skills necessary to lead and interact effectively with others, in both one-on-one and group settings. The workshop will focus on techniques, situations, and challenges that relate specifically to leading and managing in the scientific workplace. It will emphasize learning by doing and will involve role playing, giving and receiving feedback, and group problem solving. Much of the learning will be peer-to-peer. Participants will be expected to discuss their own experiences and listen to others as they discuss theirs.

The workshop will help participants identify areas where they need guidance and growth, as well as how to capitalize on areas of strength. Participants will have the opportunity to share their experiences and challenges with others and to receive feedback and guidance from others with experience in leading scientists in a variety of settings. At the end of the course, participants will be linked through a unique on-line community in which they can continue learning from one another and from the course instructors.

Key focus areas of the workshop will include:

  • Recognizing and understanding leadership in a science setting
  • Using negotiation as a tool in scientific discussions and problem solving
  • Identifying and resolving conflicts in the lab
  • Dealing with difficult people and situations
  • Communicating your ideas and plans in a way that engages others
  • Leading effective and productive meetings
  • Becoming effective citizen scientists

For more information, please click here. If you are planning to attend this workshop, please let us know at

Back to top
1. Deliberative Interim Support Funding

The Executive Committee on Research (ECOR) is accepting applications for the December 1st deadline for Deliberative Interim Support Funding.  December is the first of three standing deadlines for these awards in Fiscal Year 2018.  The next deadline will be April 1, 2018.  

What are they?
Deliberative Interim Support Funding
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).  The Deliberative Interim Support process is open to:

  • Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
  • Investigators whose grants received scores >20th percentile.
  1. Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support for a previous submission of this grant and are now requesting support for the resubmission of the same grant.  Investigators in this category must apply through the Deliberative Interim Support process for this application regardless of the score they received.

When is the deadline?
Friday, December 1, 2017 - 5:00 PM

How do I learn more and apply?
Deliberative Interim Support Funding - Click here

2. MGH-MIT Strategic Partnership Grand Challenge 1: Diagnostics, Year 4

Grand challenge 1: Make diagnosis cost-effective and accurate, and guide individual clinical decisions based on real-time monitoring and massive patient data sets.

Award Types and Amounts:

  • 5 (five) grants at $100,000 (total costs) per team (to be spent over 1-2 years)

Letter of Intent: A Letter of intent submitted via the ECOR Online Grant Management Portal is required by December 1, 2017 if you plan on submitting a proposal. Letters of intent should include the names of the principal investigators from both MGH and MIT and a brief description of the project. Please note: Write to: AND to

Full Proposal Submission Date: January 15, 2018

Project Start Date: April 15, 2018

Submission Information: Letters of intent and applications should be submitted onlinevia the ECOR Online Grant Management Portal. This user-friendly system will allow the MGH PI to submit on behalf of the MGH-MIT team.  Click here for instructions for submitting the application and letter of intent online.

Click here for more information.

3. W.M. Keck Foundation Medical Research Program

MGH Deadline: 12/8/17

The W. M KECK FOUNDATION’S MEDICAL RESEARCH PROGRAM strives to fund endeavors that are distinctive and novel in their approach. It encourages projects that are high-risk with the potential for transformative impact. "High-risk" comprises a number of factors, including questions that push the knowledge of the field, present unconventional approaches to intractable problems, or challenge the prevailing paradigm. In all of its programs, "transformative" may mean creation of a new field of research, development of new instrumentation, technologies or methodologies enabling observations not previously possible, or discovery of knowledge that challenges prevailing perspectives. Funded projects cannot focus on clinical or translational research, treatment trials or research for the sole purpose of drug development.

This is a restricted opportunity with concept papers limited to FOUR and proposals limited to ONE PER INSTITUTION. Both Senior and Early Career investigators are encouraged to apply.

Award Amount: Research grants range from $500,000 to $5 million, and are typically about $1 million.

  • Keck is looking for BASIC, FUNDAMENTAL RESEARCH. Keck does not support clinically-oriented or disease-specific research. The ultimate application can be clinical, but the focus should be on basic underlying mechanism(s).
  • KECK HAS MOVED AWAY FROM HYPOTHESIS-DRIVEN RESEARCH. An external review committee found that hypothesis-driven research was less impactful than the development of novel basic tools, techniques, and methods.
  • Keck will only fund PROJECTS THAT FALL OUTSIDE OF THE MISSION OF PUBLIC FUNDING AGENCIES. If a proposal is declined by federal agencies (e.g., NIH), include reviewer comments verbatim, especially if it was turned down because the project was considered too high-risk or outside-of-the-box. 
  • Applications must represent priorities of INSTITUTIONAL LEADERSHIP and receive some INSTITUTIONAL SUPPORT (including coverage of indirect costs). Although not an explicit selection criterion, past successful proposals have had significant matching funding.
  • Keck places value on MULTIDISCIPLINARY and INTER-INSTITUTIONAL COLLABORATION, as well as the use of novel technology in the project.
  • For Instrumentation and Methodology proposals, DESCRIBE QUANTITATIVELY THE IMPROVEMENT (BY ORDERS OF MAGNITUDE) OVER EXISTING METHODS. It must represent a quantum leap over the state of the art. New tools and techniques should have broad applicability across disciplines.

For additional eligibility requirements and descriptions of previously funded projects, please see the program website:

Internal Submission Instructions:  Please submit a ONE-PAGE CONCEPT PAPER to ECOR at by December 8, 2017 that includes the following sections:

  • an overview of the proposed project emphasizing any unique aspects and pilot studies;
  • a description of the methodologies and key personnel;
  • a brief justification of the need for Keck support; and
  • an estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies (budgets can be rough approximations at this stage).

For questions or concerns about this opportunity, please contact Tristan Barako, Director of Development, at or 617.724.5626.

4. President’s Innovation Challenge

We are pleased to announce the seventh annual President’s Innovation Challenge for entrepreneurship. Hosted by the Harvard Innovation Labs, the Challenge harnesses the creativity, ingenuity, and diversity of our community and encourages students and postdoctoral fellows from across all of Harvard’s Schools to scrutinize the most pressing challenges of our time. We are seeking three broad categories of ideas that will make the world better: Social Impact or Cultural Enterprise, Health or Life Sciences, and Open (a track for ideas that transcend other categories).
Throughout the fall, the i-lab will offer workshops, one-on-one advising sessions, and networking events to support students interested in applying to the Challenge. In the spring, a panel of expert judges will select fifteen finalists, who will be eligible to win more than $300,000 in total prize money, including $75,000 for the winning teams in each category and $25,000 for the runners-up. Winners of the Challenge will be awarded Bertarelli Foundation Prizes, made possible by a gift from the Bertarelli Foundation, Ernesto Bertarelli (MBA 1993).
The application deadline is January 2, 2018. Students interested in the Challenge can look at the questions on the website and begin preparing.

5. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

  • Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24)
  • NCI National Clinical Trials Network – Network Lead Academic Participating Sites (UG1)
  • Diabetic Foot Consortium – Clinical Research Units (U01)
  • Collaborative Program Grant for Multidisciplinary Teams (RM1) (Clinical Trial Not Allowed)

If there is a limited submission funding opportunity you do not see listed below or you have any additional questions, please let us know at

6. Private Funding Opportunities

Please note that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submission of the award.

Please contact Corporate & Foundation Relations in the Office of Development at if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

Week of 11/10/17

  • AACR Clinical and Translational Cancer Research Fellowships, American Association for Cancer Research (AACR)
  • AACR-Loxo Oncology Pediatric Cancer Research Fellowship, American Association for Cancer Research (AACR)
  • AACR Myeloma Research Fellowship, American Association for Cancer Research (AACR)
  • AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award, American Association for Cancer Research (AACR)  
  • AACR-Triple Negative Breast Cancer Foundation Research Fellowship, American Association for Cancer Research (AACR)  
  • CURE Taking Flight Award, CURE, Citizens United for Research in Epilepsy
  • CURE Innovator Award, CURE, Citizens United for Research in Epilepsy
  • PanCAN Catalyst Grant, Pancreatic Cancer Action Network (PANCAN)
  • PanCAN Translational Research Grant, Pancreatic Cancer Action Network (PANCAN)
  • Albert Rose Established Investigator Awards, Pulmonary Fibrosis Foundation (PFF)
  • I.M. Rosenzweig Junior Investigator Awards, Pulmonary Fibrosis Foundation (PFF)
  • CART Fund, Rotary International
  • Research Grants, Whitehall Foundation, Inc.
7. NIH Update for Week Ending November 10, 2017
For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link:
Back to top
In Case You Missed It
Reminders of recently posted funding opportunities, deadlines and events

MGH ECOR Formulaic Bridge Funding Support
Application Deadline: December 7, 2017; 7th day of each month

Massachusetts Alzheimer’s Disease Research Center:  Call for 2018 Pilot Projects
Application Deadline: November 30

2019 Clinical Fellows in Dementia
Application Deadline:  July 1, 2018

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

11/16     Cognitive Interviewing
12/13     Division of Clinical Research Spotlight Series: Pitching/Consenting Research Opportunities in Acutely Ill Subject Populations

Back to top

ECOR Website

Mass General Research Institute

MGH Research Intranet

Find A Researcher

Research Help and How-To

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114